相关实验视频

Updated: Jul 15, 2026

Concurrent Quantification of Cellular and Extracellular Components of Biofilms
10:18

Concurrent Quantification of Cellular and Extracellular Components of Biofilms

Published on: December 10, 2013

8.3K

化物凝应用后唾液中的化物度:一项随机临床试验

Anna Turska-Szybka1, Zuzanna Piotrkowicz2, Maria Prokopczyk2

  • 1Department of Paediatric Dentistry, Medical University of Warsaw, Poland.

International dental journal
|May 11, 2024
PubMed
概括

使用化物凝后不冲洗会显著增加唾液化物水平. 这种方法可能有利于患有高脏病风险的患者,因此需要进一步研究凝冲洗后的效果.

关键词:
这是一种化物凝.化物离子是化物离子.随机的临床试验随机的临床试验这是唾液的唾液.

更多相关视频

Micro-dissection of Enamel Organ from Mandibular Incisor of Rats Exposed to Environmental Toxicants08:12

Micro-dissection of Enamel Organ from Mandibular Incisor of Rats Exposed to Environmental Toxicants

Published on: March 29, 2018

10.1K
Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries08:20

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries

Published on: March 31, 2021

6.3K

相关概念视频

Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...